Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review
Authors:
- Breno Sena De San-MartinBSBreno Sena De San-Martin
- Vinícius Guimarães FerreiraVFVinícius Guimarães Ferreira
- Mariana Rechia BitencourtMBMariana Rechia Bitencourt
- Paulo Cesar Gonçalves PereiraPPPaulo Cesar Gonçalves Pereira
- Emanuel CarrilhoECEmanuel Carrilho
- Nilson Antônio de AssunçãoNANilson Antônio de Assunção
- Luciani Renata Silveira de CarvalhoLCLuciani Renata Silveira de Carvalho
Open Access
- 21 October 2020
- journal article
- review article
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 64 (AHEAD) , 654-663
Abstract
Metabolomics uses several analytical tools to identify the chemical diversity of metabolites present in organisms. These metabolites are low molecular weight molecules (<1500 Da) classified as a final or intermediary product of metabolic processes. The application of this omics technology has become prominent in inferring physiological conditions through reporting on the phenotypic state; therefore, the introduction of metabolomics into clinical studies has been growing in recent years due to its efficiency in discriminating pathophysiological states. Regarding endocrine diseases, there is a great interest in verifying comprehensive and individualized physiological scenarios, in particular for growth hormone deficiency (GHD). The current GHD diagnostic tests are laborious and invasive and there is no exam with ideal reproducibility and sensitivity for diagnosis neither standard GH cut-off point. Therefore, this review was focussed on articles that applied metabolomics in the search for new biomarkers for GHD. The present work shows that the applications of metabolomics in GHD are still limited, since the little complementarily of analytical techniques, a low number of samples, GHD combined to other deficiencies, and idiopathic diagnosis shows a lack of progress. The results of the research are relevant and similar; however, their results do not provide an application for clinical practice due to the lack of multidisciplinary actions that would be needed to mediate the translation of the knowledge produced in the laboratory, if transferred to the medical setting.Keywords
This publication has 59 references indexed in Scilit:
- NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendationsMetabolomics, 2013
- Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: Insights into the metabolic effects of growth hormoneGrowth Hormone & IGF Research, 2013
- Translational biomarker discovery in clinical metabolomics: an introductory tutorialMetabolomics, 2012
- Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysisBMC Medicine, 2012
- Liquid Chromatography–High Resolution Mass Spectrometry Analysis of Fatty Acid MetabolismAnalytical Chemistry, 2011
- Metabolomics as a tool for cardiac researchNature Reviews Cardiology, 2011
- Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011
- Saliva as a Diagnostic FluidDental Clinics of North America, 2011
- Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2002
- Central Dogma of Molecular BiologyNature, 1970